Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study
Authors (first, second and last of 17)
Angiogenesis is an international peer-reviewed journal devoted to the publication of top quality original articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis in physiological and pathological conditions. As a central source for rapid communications representing the full spectrum of angiogenesis research, this multidisciplinary journal publishes innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases. Angiogenesis also reports on novel therapeutic approaches for promoting or inhibiting angiogenesis as well as new markers and techniques for disease diagnosis and prognosis.
- Publishes articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis
- Presents innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases
- Reports on novel therapeutic approaches for promoting or inhibiting angiogenesis
- Examines new markers and techniques for disease diagnosis and prognosis
Journal information
- Editor-in-Chief
-
- Andrew C. Dudley,
- Arjan W. Griffioen
- Publishing model
- Hybrid (Transformative Journal). How to publish with us, including Open Access
Journal metrics
- 9.596 (2020)
- Impact factor
- 8.689 (2020)
- Five year impact factor
- 8 days
- Submission to first decision (Median)
- 274,576 (2021)
- Downloads
Latest issue
Latest articles
-
-
In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed
Authors (first, second and last of 26)
-
A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis
Authors (first, second and last of 8)
-
TFEB controls integrin-mediated endothelial cell adhesion by the regulation of cholesterol metabolism
Authors (first, second and last of 9)
-
Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer
Authors (first, second and last of 10)
Journal updates
-
Editor Highlights
Prof. Arjan Griffioen and Dr. Andrew Dudley draw attention to outstanding journal content. The papers will be free to access until 9 May 2022.
-
Learn more about our oncology titles!
Discover more about our range of academic oncology titles at Springer Nature here
-
Introducing Our New Co-Editor-in-Chief
With great pleasure, we would like to announce that Dr. Andrew Dudley has accepted our invitation to follow on from Prof. Joyce Bischoff as the new co-Editor-in-Chief of the journal. He will work alongside the journal's established Editor Prof. Arjan Griffioen.
-
Editor's Highlights - November 2020
Profs. Arjan Griffioen, Joyce Bischoff and Dr Dudley provide their Editor-in-Chief highlights from this issue.
About this journal
- Electronic ISSN
- 1573-7209
- Print ISSN
- 0969-6970
- Abstracted and indexed in
-
- BFI List
- BIOSIS
- Baidu
- Biological Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EMBASE
- EMBiology
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information